These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24712294)

  • 1. Examining the association between utilization management and downstream cardiovascular imaging.
    Agiro A; Sylwestrzak G; Shah C; Power T; DeVries A
    Health Serv Res; 2014 Oct; 49(5):1616-37. PubMed ID: 24712294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does management of echocardiography affect use across risk groups? UM for outpatient discretionary echocardiography appeared to reduce testing rates significantly.
    Manag Care; 2013 Nov; 22(11):34-43. PubMed ID: 24409530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
    Lin J; Lingohr-Smith M; Kwong WJ
    J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators.
    Nazarian S; Reynolds MR; Ryan MP; Wolff SD; Mollenkopf SA; Turakhia MP
    J Magn Reson Imaging; 2016 Jan; 43(1):115-27. PubMed ID: 26118943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy.
    Ruddy KJ; Sangaralingham LR; Van Houten H; Nowsheen S; Sandhu N; Moslehi J; Neuman H; Jemal A; Haddad TC; Blaes AH; Villarraga HR; Thompson C; Shah ND; Herrmann J
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005984. PubMed ID: 32106704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Stress Echocardiography in Patients With Low-Intermediate or High Short-Term (10 Years) Versus Low (<39%) or High (≥39%) Lifetime Predicted Risk of Cardiovascular Disease According to the American College of Cardiology/American Heart Association 2013 Cardiovascular Risk Calculator.
    Yao SS; Supariwala A; Yao A; Dukkipati SS; Wyne J; Chaudhry FA
    Am J Cardiol; 2015 Sep; 116(5):725-9. PubMed ID: 26138377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of LA volumes assessed by transthoracic 3D echocardiography: comparison with 2D echocardiography.
    Wu VC; Takeuchi M; Kuwaki H; Iwataki M; Nagata Y; Otani K; Haruki N; Yoshitani H; Tamura M; Abe H; Negishi K; Lin FC; Otsuji Y
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1025-1035. PubMed ID: 24011776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
    Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
    Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Cardiac Rehabilitation With All-Cause Mortality Among Patients With Cardiovascular Disease in the Netherlands.
    Eijsvogels TMH; Maessen MFH; Bakker EA; Meindersma EP; van Gorp N; Pijnenburg N; Thompson PD; Hopman MTE
    JAMA Netw Open; 2020 Jul; 3(7):e2011686. PubMed ID: 32716516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population: The Copenhagen City Heart Study.
    Biering-Sørensen T; Biering-Sørensen SR; Olsen FJ; Sengeløv M; Jørgensen PG; Mogelvang R; Shah AM; Jensen JS
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28264868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risks associated with dipeptidyl peptidase-4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study.
    Komamine M; Kajiyama K; Ishiguro C; Uyama Y
    Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1166-1174. PubMed ID: 31338935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of utilization management on readmissions among patients with cardiovascular disease.
    Lessler DS; Wickizer TM
    Health Serv Res; 2000 Feb; 34(6):1315-29. PubMed ID: 10654833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study.
    Eliasson B; Liakopoulos V; Franzén S; Näslund I; Svensson AM; Ottosson J; Gudbjörnsdottir S
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):847-54. PubMed ID: 26429401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dalfampridine prior authorization program: a cohort study.
    Gleason PP; Phillips J; Fenrick BA; Delgado-Riley A; Starner CI
    J Manag Care Pharm; 2013; 19(1):18-25. PubMed ID: 23383704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse.
    Wollschlaeger BA; Willson TM; Montejano LB; Ronquest NA; Nadipelli VR
    J Opioid Manag; 2017; 13(4):207-220. PubMed ID: 28953313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Trends in Utilization of Transthoracic Echocardiography for Common Outpatient Pediatric Cardiology Diagnoses over the Past 15 Years.
    Sachdeva R; Travers CD; McCracken CE; Samai C; Campbell RM; Slesnick TC; Border WL
    J Am Soc Echocardiogr; 2017 Mar; 30(3):201-208. PubMed ID: 28259302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do imaging studies performed in physician offices increase downstream utilization?: an empiric analysis of cardiac stress testing with imaging.
    Chen J; Fazel R; Ross JS; McNamara RL; Einstein AJ; Al-Mallah M; Krumholz HM; Nallamothu BK
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):630-7. PubMed ID: 21679898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate.
    Christensen RH; von Scholten BJ; Hansen CS; Heywood SE; Rosenmeier JB; Andersen UB; Hovind P; Reinhard H; Parving HH; Pedersen BK; Jørgensen ME; Jacobsen PK; Rossing P
    Eur J Prev Cardiol; 2017 Sep; 24(14):1517-1524. PubMed ID: 28650207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.
    Delea TE; Gokhale M; Makin C; Hussein MA; Vanderpoel J; Sandman T; Chang J; Sung J; Pinkston P; Gause D; Jackson M
    J Manag Care Pharm; 2007 May; 13(4):349-59. PubMed ID: 17506601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States.
    Lu M; Oladapo A; Wu Y; Farahbakhshian S; Ewenstein B
    J Manag Care Spec Pharm; 2021 Feb; 27(2):175-185. PubMed ID: 33307935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.